TrialProceedings of the National Academy of Sciences of the United States of America2019

Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson's disease.

Vinicius M Fava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.